GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (STU:34D) » Definitions » Market Cap

Diasorin SpA (STU:34D) Market Cap : €5,492 Mil (As of Dec. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Diasorin SpA's share price for the quarter that ended in Jun. 2024 was €91.78. Diasorin SpA's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 53 Mil. Therefore, Diasorin SpA's market cap for the quarter that ended in Jun. 2024 was €4,893 Mil.

Diasorin SpA's quarterly market cap declined from Dec. 2023 (€4,912 Mil) to Mar. 2024 (€4,723 Mil) but then increased from Mar. 2024 (€4,723 Mil) to Jun. 2024 (€4,893 Mil).

Diasorin SpA's annual market cap declined from Dec. 2021 (€9,173 Mil) to Dec. 2022 (€6,716 Mil) and declined from Dec. 2022 (€6,716 Mil) to Dec. 2023 (€4,912 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Diasorin SpA's Enterprise Value for Today is €6,304 Mil.


Diasorin SpA Market Cap Historical Data

The historical data trend for Diasorin SpA's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Market Cap Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,355.72 9,299.00 9,172.74 6,715.56 4,912.32

Diasorin SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,571.88 4,912.32 4,722.78 4,893.33 5,555.52

Competitive Comparison of Diasorin SpA's Market Cap

For the Diagnostics & Research subindustry, Diasorin SpA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Market Cap distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Market Cap falls into.



Diasorin SpA Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Diasorin SpA's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€92.06*53.36
=€4,912

Diasorin SpA's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=€91.78*53.3159
=€4,893

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA  (STU:34D) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Diasorin SpA Market Cap Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines